Cancers

May 26, 2020| Posted in: Cancers, Hematologic Disorders, Treatment

Treatment of AML in the Elderly Has Changed Significantly

Courtney  DiNardo, MD, Associate Professor at the University…
May 25, 2020| Posted in: Cancers, News, Regulations, Treatment

FDA Approves New First-line Therapy for Rare Lung Cancer

The U.S. Food and Drug Administration (FDA) has…
May 22, 2020| Posted in: Cancers, Hematologic Disorders, Treatment

PTG-300 Showing Promise to Control Hemocrit Levels in Polycythemia Vera

Ronald Hoffman, MD at The Icahn School of Medicine…
May 21, 2020| Posted in: Cancers, Congenital And Genetic Conditions, News, Treatment

Data from Von-Hippel-Lindau Clinical Trial Shows Promise for HIF-2a Inhibitor

Eric Jonasch, MD, Professor, Department of Genitourinary Medical…
May 19, 2020| Posted in: Cancers, Gastrointestinal Diseases, News, Regulations, Treatment

FDA Approves New Treatment for 4th-Line Treatment for GIST

The U.S. Food and Drug Administration (FDA) has…
May 18, 2020| Posted in: Cancers, News, Regulations, Skin Conditions, Treatment

FDA Approves New Drug for Kaposi Sarcoma

The U.S. Food and Drug Administration (FDA) has…
May 15, 2020| Posted in: Cancers

Glioblastoma

Glioblastoma is a very aggressive brain tumor. Most…
May 9, 2020| Posted in: Cancers, News, Regulations, Treatment

FDA Approves One Drug for Three Rare Cancer Subtypes

The  U.S. Food and Drug Administration (FDA) has…
May 7, 2020| Posted in: Cancers, Diagnosis, Hematologic Disorders, Lysosomal Storage Disorders, Metabolic Disorders, News, Treatment

Journal Watch: COVID-19, Neimann-Pick, Sickle Cell, Multiple Myeloma

CheckRare Journal Watch: COVID-19, Neimann-Pick, Sickle Cell, Multiple…
May 4, 2020| Posted in: Cancers, Drug Development, Hematologic Disorders, News, Regulations, Treatment

FDA Approves Subcutaneous Formulation of Daratumumab to Treat Multiple Myeloma

The U.S. Food and Drug Administration (FDA) has…

Tenosynovial Giant Cell Tumor (TGCT)

Tenosynovial giant cell tumor (TGCT) is a non-malignant tumor involving the joint synovium, bursae, and tendon sheath. These rare tumors are sometimes referred to as giant cell tumor of the tendon sheath (GCT-TS) and/or pigmented villonodular synovitis (PVNS).

CME Program: Gaucher Disease Highlights from WORLDSymposium 2020

Neal Weinreb, MD, FACP highlights the latest information about Gaucher disease from WORLDSymposium and provides expert analysis of its clinical relevance to help health care providers better care for patients with this rare disease.

Rare Disease Clinical Trials CME Program

Learn about clinical trials and rare diseases through these brief courses that are certified for CME and CNE credit.
  • Heather Lau, MD, MS, NYU School of Medicine, New York, NY
  • Morie A Gertz, MD, Mayo Clinic, Rochester, MN
  • Timothy Craig, DO, Penn State University, Hershey, PA
  • Eric T. Wong, MD, Harvard Medical School, Boston, MA

Cancers

Topics

  • Sign up
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
We do not share your personal details with anyone.